Annual Retained Earnings
-$7.73 M
+$10.39 M+57.34%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual retained earnings is -$7.73 million, with the most recent change of +$10.39 million (+57.34%) on December 31, 2023.
- During the last 3 years, XLO annual retained earnings has risen by +$11.85 million (+60.53%).
- XLO annual retained earnings is now -94.57% below its all-time high of -$3.97 million, reached on December 1, 2016.
Performance
XLO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$370.66 M
-$14.02 M-3.93%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly retained earnings is -$370.66 million, with the most recent change of -$14.02 million (-3.93%) on September 30, 2024.
- Over the past year, XLO quarterly retained earnings has dropped by -$45.15 million (-13.87%).
- XLO quarterly retained earnings is now -335.63% below its all-time high of -$85.09 million, reached on December 31, 2020.
Performance
XLO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
XLO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.3% | -13.9% |
| 3 y3 years | +60.5% | -13.9% |
| 5 y5 years | +35.1% | -13.9% |
XLO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.1% | -130.4% | at low |
| 5 y | 5-year | at high | +60.5% | -335.6% | at low |
| alltime | all time | -94.6% | +60.5% | -335.6% | at low |
Xilio Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$370.66 M(+3.9%) |
| Jun 2024 | - | -$356.64 M(+4.1%) |
| Mar 2024 | - | -$342.71 M(+5.3%) |
| Dec 2023 | -$7.73 M(-57.3%) | -$325.51 M(+5.7%) |
| Sep 2023 | - | -$307.86 M(+5.8%) |
| Jun 2023 | - | -$291.11 M(+7.1%) |
| Mar 2023 | - | -$271.75 M(+9.1%) |
| Dec 2022 | -$18.11 M | -$249.11 M(+9.9%) |
| Sep 2022 | - | -$226.64 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$206.85 M(+13.5%) |
| Mar 2022 | - | -$182.24 M(+13.3%) |
| Dec 2021 | -$19.35 M(-1.1%) | -$160.89 M(+14.0%) |
| Sep 2021 | - | -$141.19 M(+13.0%) |
| Jun 2021 | - | -$124.93 M(+46.8%) |
| Dec 2020 | -$19.57 M(+36.4%) | -$85.09 M |
| Dec 2019 | -$14.35 M(+20.5%) | - |
| Dec 2018 | -$11.91 M(+44.4%) | - |
| Dec 2017 | -$8.25 M(+107.7%) | - |
| Dec 2016 | -$3.97 M | - |
FAQ
- What is Xilio Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Xilio Therapeutics?
- What is Xilio Therapeutics annual retained earnings year-on-year change?
- What is Xilio Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly retained earnings year-on-year change?
What is Xilio Therapeutics annual retained earnings?
The current annual retained earnings of XLO is -$7.73 M
What is the all time high annual retained earnings for Xilio Therapeutics?
Xilio Therapeutics all-time high annual retained earnings is -$3.97 M
What is Xilio Therapeutics annual retained earnings year-on-year change?
Over the past year, XLO annual retained earnings has changed by +$10.39 M (+57.34%)
What is Xilio Therapeutics quarterly retained earnings?
The current quarterly retained earnings of XLO is -$370.66 M
What is the all time high quarterly retained earnings for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly retained earnings is -$85.09 M
What is Xilio Therapeutics quarterly retained earnings year-on-year change?
Over the past year, XLO quarterly retained earnings has changed by -$45.15 M (-13.87%)